Hypermarcas (OTCMKTS:HYPMY – Get Free Report) issued its earnings results on Thursday. The company reported $0.13 EPS for the quarter, Zacks reports. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The company had revenue of $414.22 million during the quarter.
Hypermarcas Stock Performance
HYPMY traded down $0.05 during trading hours on Friday, hitting $4.05. 6,284 shares of the stock were exchanged, compared to its average volume of 15,007. The stock has a 50-day simple moving average of $4.48 and a 200-day simple moving average of $4.42. Hypermarcas has a 12 month low of $3.17 and a 12 month high of $5.50. The stock has a market cap of $2.56 billion, a price-to-earnings ratio of 17.59 and a beta of 0.73. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Read More
- Five stocks we like better than Hypermarcas
- Look who’s buying 2 tonnes of gold… per week!
- The gold chart Wall Street is terrified of…
- Iran isn’t the real war
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
